Systems Biological Responses to Influenza Vaccination in an HIV-infected and HIV-uninfected Adult Population in Kampala, Uganda
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2015
Price : $35 *
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics; Pharmacogenomic
- 22 Apr 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Mar 2014 according to ClinicalTrials.gov record.
- 16 Jan 2014 Status changed from recruiting to active, no longer recruiting according to ClinicalTrials.gov record.